Singapore-based vascular access device company Advent Access said it has received the CE Mark for its av-Guardian technology designed to create vascular access for dialysis patients. The device-guided needling platform features the company’s “guardian guide-door” technology for accessing arteriovenous fistulas, which it claims can reduce wear and tear on the dialysis patient’s veins. The technology […]
Dialysis
Immunicom raises $11M for cancer treatment device
Biotech company Immunicom, which has developed a non-pharmaceutical, late-stage cancer treatment, has raised $11 million in a Series B investment round. Several private equity family offices participated in the round, increasing Immunicom’s overall capital raised to $20 million. The San Diego-based company won FDA breakthrough device designation in 2018 for its Immunopheresis therapy, which is […]
Fresenius OKs $748m stock buyback
Fresenius (NYSE:FMS) said last week that its board authorized a stock buyback worth up to €660 million, or just more than 3% of its total shares. The one-year authorization to repurchase up to 12 million shares is worth about $748 million; on the day of any trades the Bad Homburg, Germany-based renal care giant can’t miss that […]
Fresenius posts Street-beating Q1 earnings
Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) rose slightly today after the dialysis-focused device maker beat expectations on Wall Street with its first quarter earnings release. The Bad Homburg, Germany-based company posted profits of $303.2 million, or 99¢ per share, on sales of approximately $4.62 billion for the three months ended March 31, seeing the bottom […]
FTC grants final approval for Fresenius’s $2B buyout of NxStage
The U.S. Federal Trade Commission said yesterday that it granted a final order of approval to Fresenius Medical Care (NYSE:FMS; ETR:FRE) for its $2 billion acquisition of NxStage Medical. The approval came with a caveat that the companies divest their assets and rights to research, develop, manufacture, market and sell NxStage’s bloodline tubing sets intended for use […]
Fresenius wins FDA breakthrough device nod for fluid management software
Fresenius (NYSE:FMS) said yesterday that it won FDA breakthrough device designation for its computer-assisted ultrafiltration control software intended to improve fluid management during hemodialysis. The Waltham, Mass.-based company said that the software is designed to work with its newer hemodialysis machines using its CLiC device. Fresenius said that with the software, it hopes to create a […]
FTC gives the go ahead to Fresenius, NxStage merger
The U.S. Federal Trade Commission said yesterday that it cleared Fresenius (NYSE:FMS) in its $2 billion acquisition of NxStage Medical (NSDQ:NXTM). As part of the approval, NxStage will have to part ways with its bloodline tubing set business, offloading them to B. Braun, according to the regulatory agency. The vote to approve the merger was split, however, […]
Fresenius launches 2008T BlueStar hemodialysis machine in U.S.
Fresenius Medical Care (NYSE:FMS) said today that it launched its 2008T BlueStar hemodialysis machine, touting more than 30 improvements from previous device models. The Waltham, Mass.-based company said that the new system is intended to allow for simpler operation and maintenance with additional treatment options, and added that the system features a number of newly automated technologies. […]
Laminate Medical brings in $12m for dialysis vascular support device
Israeli medtech start-up Laminate Medical Technologies said today that it raised $12 million in a new round of financing slated to support its VasQ vascular support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by […]
U.S. gov’t shutdown again delays closing for Fresenius-NxStage merger
Fresenius (NYSE:FMS) said today that an interruption to the FTC’s review of its merger with NxStage Medical (NSDQ:NXTM), caused by the partial U.S. government shutdown, has again delayed the end-date of the deal which has now been extended to August 6, 2019. The end-date is not hard-set, Fresenius said, and could occur on an earlier date if there have […]
Baxter launches on-demand peritoneal dialysis solution device trial
Baxter (NYSE:BAX) said yesterday that it launched an FDA-cleared clinical trial of its on-demand peritoneal dialysis solution generation system intended to allow patients to make peritoneal dialysis solutions in small batches at home. The system is designed to use a small water filtration device, concentrates and Deerfield, Ill.-based Baxter’s Amia automated peritoneal dialysis system to turn a […]